The first successful desensitization protocol in exenatide allergy: a case report

BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists are important treatment options in obese patients with type 2 diabetes. To date, few immediate allergic reactions due to GLP-1 receptor agonists were reported. One report revealed that a patient with a level 1 anaphylaxis according to Bri...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeğit, Osman Ozan, Sarıbeyliler, Göktuğ, Karadağ, Pelin, Demir, Semra, Gül, Nurdan, Ünal, Derya, Gelincik Akkor, Aslı
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838064/
https://www.ncbi.nlm.nih.gov/pubmed/36639791
http://dx.doi.org/10.1186/s13223-023-00761-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838064/
https://www.ncbi.nlm.nih.gov/pubmed/36639791
http://dx.doi.org/10.1186/s13223-023-00761-y

Ejemplares similares